PNC FINANCIAL SERVICES GROUP, INC. - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 53 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$594
+51.5%
1,0050.0%0.00%
Q4 2022$392
-60.8%
1,0050.0%0.00%
Q3 2022$1,000
-50.0%
1,0050.0%0.00%
Q2 2022$2,0001,0050.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 129,891$69,0000.01%
Hudson Bay Capital Management LP 230,000$123,0000.00%
Renaissance Technologies 1,879,137$1,004,0000.00%
ROYAL BANK OF CANADA 89$00.00%
Gradient Investments LLC 63$00.00%
VANGUARD GROUP INC 858,416$459,0000.00%
OPTIMUM INVESTMENT ADVISORS 16$00.00%
Focused Wealth Management, Inc 222$00.00%
FEDERATED HERMES, INC. 907$1,0000.00%
JANE STREET GROUP, LLC 24,985$13,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders